MedTrace Logo

Evaluation of Composite Veneers Fabricated by 3D Printing and Milling Technologies

NCT07756333 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 14

Last updated 2026-08-12

No results posted yet for this study

Summary

The clinical study aimed to evaluate the clinical performance, color stability, and wear of indirect composite veneers produced using 3D printing and milling technologies.

Conditions

  • Dental Restoration, Permanent
  • Dental Restoration Wear

Interventions

OTHER

Group I (n=28): were restored with VarseoSmile TriniQ, Bego

A total of fifty-six anterior indirect veneers will be fabricated using 3D printing and milling technologies. The veneers will be divided into two groups according to the technique of fabrication. Group I: 28 veneers will be done using 3D printing technology (VarseoSmile TriniQ, Bego), and group II: 28 veneers will be done using milling technology (Cerasmart 270, GC). Veneer restorations will be fabricated checked, and cemented, then will be evaluated using the modified FDI criteria at baseline, three months, six months, and one year. Moreover, color stability and surface wear of the restorations will be evaluated in each follow-up session.

OTHER

Group II (n=28): were restored with Cerasmart 270, GC

A total of fifty-six anterior indirect veneers will be fabricated using 3D printing and milling technologies. The veneers will be divided into two groups according to the technique of fabrication. Group I: 28 veneers will be done using 3D printing technology (VarseoSmile TriniQ, Bego), and group II: 28 veneers will be done using milling technology (Cerasmart 270, GC). Veneer restorations will be fabricated checked, and cemented, then will be evaluated using the modified FDI criteria at baseline, three months, six months, and one year. Moreover, color stability and surface wear of the restorations will be evaluated in each follow-up session.

Sponsors & Collaborators

  • youssef alaa

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-05-01
Primary Completion
2026-08-05
Completion
2026-08-05

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07756333 on ClinicalTrials.gov